RetinalGenix Technologies Inc. Files 8-K
Ticker: RTGN · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1836295
| Field | Detail |
|---|---|
| Company | Retinalgenix Technologies Inc. (RTGN) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financials
TL;DR
RetinalGenix filed an 8-K on Feb 19, 2025, reporting a material agreement and financials. Check for details.
AI Summary
RetinalGenix Technologies Inc. filed an 8-K on February 20, 2025, reporting a material definitive agreement and financial statements. The filing indicates the company's principal executive offices are located at 409 Apollo Beach Blvd, Suite 6, Apollo Beach, FL 33572, with a business phone number of (415) 578-9583. The company is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This 8-K filing signals a significant event for RetinalGenix Technologies Inc., potentially involving a new material agreement or updated financial information that could impact investors.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting a material definitive agreement and financial statements, without immediate indication of significant financial distress or major operational changes.
Key Players & Entities
- RetinalGenix Technologies Inc. (company) — Registrant
- February 19, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 409 Apollo Beach Blvd , Suite 6 Apollo Beach , FL 33572 (address) — Address of principal executive offices
- (415) 578-9583 (phone_number) — Registrant's telephone number
- 3841 (sic_code) — Standard Industrial Classification
FAQ
What is the specific nature of the material definitive agreement reported in this 8-K?
The filing states 'Entry into a Material Definitive Agreement' as an item information, but the specific details of the agreement are not provided in the provided text.
When was the earliest event reported in this filing?
The earliest event reported was on February 19, 2025.
Where are RetinalGenix Technologies Inc.'s principal executive offices located?
The principal executive offices are located at 409 Apollo Beach Blvd, Suite 6, Apollo Beach, FL 33572.
What is the SIC code for RetinalGenix Technologies Inc.?
The Standard Industrial Classification code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
What is the registrant's telephone number?
The registrant's telephone number is (415) 578-9583.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding RetinalGenix Technologies Inc. (RTGN).